Clinical Obstetrics
Poster Session 1
Pranaya Chilukuri, MD, MPH (she/her/hers)
Resident Physician
University of Kentucky Albert B. Chandler Hospital
Lexington, KY, United States
Charlotte McCarley, MD (she/her/hers)
Fellow
University of Alabama at Birmingham
Hoover, AL, United States
Juliann Wang, BS
University of Alabama at Birmingham School of Medicine
Birmingham, AL, United States
Brian M. Casey, MD
University of Alabama at Birmingham
Birmingham, AL, United States
Rachel Sinkey, MD (she/her/hers)
University of South Florida
Tampa, FL, United States
Caitlin Clevenger, PhD
University of Alabama at Birmingham
Birmingham, AL, United States
Opioid use disorder (OUD) is a leading cause of maternal mortality, particularly postpartum (PP). The objective of this systematic review is to provide a qualitative summary of published interventions for PP opioid abstinence or reduction.
Study Design: This systematic review was registered with PROSPERO (ID CRD42023405688). A comprehensive search of CINAHL, MEDLINE, PsycINFO, and EMBASE was conducted for intervention trials with ≥ 5 subjects aimed at opioid use reduction or abstinence in the first year PP. Studies without a comparison group or interventions continued PP were excluded. All abstracts were summarized, if eligible, by 2 independent reviewers. Risk of bias was assessed with the Cochrane Risk of Bias or Newcastle-Ottawa Scale.
Results: Of 812 articles screened, 14 were assessed for full-text eligibility and 3 were included for full-text review (Table). Study 1 assessed a therapeutic workplace (TW) that provided a job with reimbursement for opioid abstinence. Abstinence was increased in TW (n=20) compared to usual care (UC) (n=20) in the first 6 months PP, but the change was not significant (52% vs 33%, p=0.06). Study 2 assessed a comprehensive perinatal clinic’s effect on patients with substance use and demonstrated drug use abstinence during pregnancy in 93/97 (96%) of participants. However, only 10% of patients in the study had OUD, 22% were lost to follow up PP, and 13% relapsed to heavy drug use by 6 months PP. Study 3 compared motivational interviewing to UC in 60 participants and found a significant reduction in PP opioid use (23% vs 60%, p=0.004).
Conclusion:
Despite the large contribution of OUD to maternal mortality, only 3 intervention studies have assessed strategies to reduce opioid use PP. Existing studies vary widely in intervention type and effect. Our systematic review illustrates the paucity of evidence-based interventions for PP OUD. This underscores the pressing need to further address this significant public health concern and contributor to maternal mortality.